Hudson Bay Capital Management’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Hudson Bay Capital Management’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-60,637	Closed	-$605K	–	1355
2022 Q3	$605K	Hold	60,637	–	–	0.01%	886
2022 Q2	$599K	Hold	60,637	–	–	﹤0.01%	974
2022 Q1	$595K	Hold	60,637	–	–	0.01%	864
2021 Q4	$591K	Hold	60,637	–	–	0.01%	846
2021 Q3	$596K	Sell	60,637 -130,000	-68%	-$1.27M	0.01%	799
2021 Q2	$1.86M	Hold	190,637	–	–	0.02%	640
2021 Q1	$1.9M	Buy	+190,637	New	+$1.95M	0.02%	580

Hudson Bay Capital Management's FLAC Position: Q4 2022 in Review

Hudson Bay Capital Management sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 60,637 shares — an estimated $605K sold.

Hudson Bay Capital Management first reported a position in FLAC in Q1 2021 and held it in 7 quarters. The position peaked at $1.9M in Q1 2021. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

Hudson Bay Capital Management reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Hudson Bay Capital Management sold 60,637 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $605K.
Hudson Bay Capital Management first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2021 and held it in 7 quarters.
Hudson Bay Capital Management's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $1.9M in Q1 2021.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Hudson Bay Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.